3D printed medicine for the management of chronic diseases: The road less travelled
Authors:
- Ryan VargheseRVRyan Varghese
- Sahil SalviSSSahil Salvi
- Purab SoodPSPurab Sood
- Jainam KarsiyaJKJainam Karsiya
- Dileep KumarDKDileep Kumar
Open Access
- 1 March 2022
- journal article
- Published by Elsevier in Annals of 3D Printed Medicine
- Vol. 5
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Desktop 3D printing of controlled release pharmaceutical bilayer tabletsInternational Journal of Pharmaceutics, 2014
- Medication Nonadherence in DiabetesDiabetes Care, 2012
- Three‐Dimensional Human Tissue Chips Fabricated by Rapid and Automatic Inkjet Cell PrintingAdvanced Healthcare Materials, 2012
- Combine and conquer: advantages and disadvantages of fixed‐dose combination therapyDiabetes, Obesity and Metabolism, 2012
- Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countriesThe Lancet, 2010
- Physicochemical Characterization of Hot Melt Extruded Bicalutamide–Polyvinylpyrrolidone Solid DispersionsJournal of Pharmaceutical Sciences, 2010
- The burden and costs of chronic diseases in low-income and middle-income countriesThe Lancet, 2007
- An Update on the Etiology and Epidemiology of Diabetes MellitusAnnals of the New York Academy of Sciences, 2006
- Preventing chronic diseases: how many lives can we save?The Lancet, 2005
- The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheresJournal of Microencapsulation, 2002